Contact
 

Join us for an interactive session where we will review exciting developments that are opening new avenues in HIV vaccine science. The session features Margaret McCluskey of USAID, Mitchell Warren of AVAC, Nina Russell from the Gates...

The Enterprise launched Timely Topics in HIV Vaccines to analyze, address and respond to strategic issues in the field.  We are seeking proposals for hot topics that will help move the HIV vaccine endeavor forward.  For more information...

Bloomberg ran a piece on the Pox-Protein Public Private Partnership (P5) and their plans to improve on the RV144 Thai HIV vaccine trial results. Check it out,...

In its World AIDS Vaccine Day statement, the Public Health Agency of Canada noted that through the Canadian HIV Vaccine Intiative, five new research teams are...

In an editorial published in the Mail & Guardian, Michel Sidibe, Chidi Nweneka and Margaret McGlynn wrote that despite the advances in the management of HIV, an effective vaccine to prevent HIV would save billions.  The full...

The U.S. Military HIV Research Program issued a statement by COL. Nelson Michael highlighting the Military's efforts to develop a globally effective HIV vaccine.  The statement is available here, ...

Enterprise stakeholders are conducting activities/events all around the world to commemorate HIV Vaccine Awareness Day, 18 May.  Check out our comprehensive listing of activities going on this week, ...

Update on Future Conferences - April 23, 2012

The Secretariat of the Global HIV Vaccine Enterprise provided an update on future AIDS Vaccine conferences.  In the update to stakeholders, Bill Snow  noted that recent breakthroughs in vaccines and other HIV prevention technologies...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account